Improved Overall Survival after Contralateral Risk-Reducing Mastectomy in Brca1/2 Mutation Carriers with a History of Unilateral Breast Cancer: A Prospective Analysis

Author:

AM Heemskerk-Gerritsen Bernadette1,Rookus Matti A2,Aalfs Cora M3,Aussems Margreet GEM4,Collée Johanna M5,Jansen Liesbeth6,Kets C Marleen7,Keymeulen Kristien BMI8,Koppert Linetta B9,Meijers-Heijboer Hanne EJ10,Mooij Thea M2,Tollenaar Rob AEM11,Vasen Hans FA12,Hooning Maartje J1,Seynaeve Caroline1,

Affiliation:

1. Department of Medical Oncology; Family Cancer Clinic; Erasmus MC Cancer Institute; Rotterdam the Netherlands

2. Department of Epidemiology; NKI-AVL; Amsterdam the Netherlands

3. Department of Clinical Genetics; AMC; Amsterdam the Netherlands

4. Department of Medical Genetics; UMCU; Utrecht the Netherlands

5. Department of Clinical Genetics; EMC; Rotterdam the Netherlands

6. Department of Surgery; UMCG; Groningen the Netherlands

7. Department of Human Genetics; Radboud University Nijmegen Medical Centre; Nijmegen the Netherlands

8. Department of Surgery; MUMC; Maastricht the Netherlands

9. Department of Surgery; Erasmus MC Cancer Institute; Rotterdam the Netherlands

10. Department of Human Genetics; VUMC; Amsterdam the Netherlands

11. Department of Surgery; LUMC; Leiden the Netherlands

12. Foundation for Detection of Hereditary Tumours; Leiden the Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3